1. Adolfsson, R., Bucht, G., Lancranjan, I., Said, S., Seif, S., Svennerholm, L., and Winblad, B., 1983, Endocrine and metabolic effects of vasopressin in patients with multiinfarct dementia, in: Neuropeptide and Hormone Modulation of Brain Function and Homeostasis (J. M. Orday, J. R. Sladek, and B. Reisberg, eds.), Raven Press, New York, in press.
2. Anderson, L. T., David, R., Bonnet, K., and Daneis, J., 1979, Passive avoidance learning in Leasch-Nyhan disease: Effect of l-desamino-8-arginine-vasopressin, Life Sci.
24:905.
3. Bargmann, W., and Scharrer, E., 1951, The site of origin of the hormones of the posterior pituitary, Am. Sci.
39:255.
4. Barker, J. L., 1976, Peptides: Roles in neuronal excitability, Physiol. Rev.
56:435.
5. Bentley, P. J., 1969, The effect of valinomycin on the toad bladder: Antagonism to vasopressin and aldosterone, J. Endocrinol.
45:287.